CNS & Neurology — API & Bulk Drug Suppliers in India

sodium-channel antiepileptic — tablet and controlled-release formulations for focal seizures and trigeminal neuralgia.

peripheral dopa-decarboxylase inhibitor — combination partner of levodopa.

acetylcholinesterase inhibitor — tablet formulations for Alzheimer-type dementia.

sodium-channel-stabilising antiepileptic — tablet formulations for focal seizures and bipolar maintenance.

broad-spectrum antiepileptic — tablet and solution formulations for focal and generalised seizures.

dopamine precursor — tablet formulations, with carbidopa, for Parkinson's disease.

endogenous sleep-cycle hormone — supplement formulations for jet lag and sleep-onset support.

NMDA-receptor antagonist — tablet formulations for moderate-to-severe dementia.

dopamine agonist — tablet formulations for Parkinson's disease and restless legs syndrome.

sulfa-substituted antiepileptic — tablet formulations for seizures and migraine prophylaxis.

broad-spectrum antiepileptic — tablet and syrup formulations for generalised and focal seizures.

glutamatergic relapse-prevention agent — tablet formulations for alcohol-dependence maintenance.

selective synaptic-vesicle 2A ligand — tablet formulations for focal-onset seizures.

partial opioid agonist — sublingual tablet and patch formulations for pain and dependence therapy.

central muscle relaxant — tablet formulations, typically with paracetamol, for muscle spasm.

fourth-generation calcium-channel blocker — tablet formulations for hypertension, N- and L-type channels.

phospholipid intermediate — tablet formulations for stroke recovery and cognitive support.

ryanodine-receptor antagonist — capsule and injection formulations for malignant hyperthermia and spasticity.

NF-E2-related-factor-2 activator — capsule formulations for relapsing multiple sclerosis.

potent synthetic opioid — transdermal patch and injection formulations for severe pain under controlled-drug rules.

sphingosine-1-phosphate receptor modulator — capsule formulations for relapsing multiple sclerosis.

slow sodium-channel inactivation antiepileptic — tablet and injection formulations for focal seizures.

full opioid agonist — tablet and solution formulations for opioid-dependence therapy.

opioid antagonist — injection formulations for opioid overdose reversal.

opioid antagonist — tablet formulations for alcohol and opioid-dependence relapse prevention.

cerebroselective calcium-channel blocker — tablet formulations for delayed cerebral ischaemia after aneurysmal bleed.

anticholinergic muscle relaxant — tablet formulations for painful musculoskeletal spasm.

sodium-channel antiepileptic — tablet and suspension formulations for focal seizures.

AMPA-receptor antagonist — tablet formulations for focal and generalised seizures.

barbiturate antiepileptic — tablet and injection formulations for generalised and focal seizures.

hydantoin antiepileptic — tablet, capsule and injection formulations for seizure control.

irreversible MAO-B inhibitor — tablet formulations for Parkinson's disease.

glutamate-modulating agent — tablet formulations for amyotrophic lateral sclerosis.

dual cholinesterase inhibitor — capsule, patch and solution formulations for Alzheimer-type dementia.

non-ergot dopamine agonist — tablet formulations for Parkinson's disease and restless legs syndrome.

MAO-B inhibitor — tablet formulations as adjunct therapy in Parkinson's disease.

5-HT1B/1D agonist triptan — tablet and injection formulations for acute migraine.

mu-opioid agonist and noradrenaline reuptake inhibitor — tablet formulations, including extended-release, for moderate to severe pain.

dihydro-orotate dehydrogenase inhibitor — tablet formulations for relapsing multiple sclerosis.

sulfonamide antiepileptic — capsule formulations for focal seizures.

free-radical scavenger — injection formulations for amyotrophic lateral sclerosis and stroke care.

calcium channel blocker for migraine prophylaxis — tablet formulations for migraine and vertigo.

alpha-2-delta ligand for neuropathic pain — capsule and tablet formulations for neuropathic pain and as adjunct in epilepsy.

pooled human normal immunoglobulin — injection formulations for immunodeficiency and neurological indications.

alpha-2-delta ligand — capsule formulations for neuropathic pain, fibromyalgia and as antiepileptic adjunct.

5-HT1B/1D agonist — tablet and wafer formulations for acute migraine.

anticholinergic antiparkinsonian — tablet and syrup formulations for parkinsonism and drug-induced extrapyramidal symptoms.